Monday, 24 July 2017

Quintiles bags Frost and Sullivan's 'APAC CRO of the Year' award

19 October 2015 | News | By BioSpectrum Bureau

Quintiles bags Frost and Sullivan's 'APAC CRO of the Year' award

 Quintiles has recieved Asia Pacific Contract Research Organization company of the Year

Quintiles has recieved Asia Pacific Contract Research Organization company of the Year

Singapore: Quintiles has recieved Asia Pacific Contract Research Organization company of the Year recognition by Frost & Sullivan.

"Quintiles is the clear market leader in the Asia Pacific CRO landscape," said Ms Rhenu Bhuller, partner, healthcare, Frost & Sullivan. "Asia Pacific is a strong focus area for multinational CROs and we evaluated the top five on two key factors, 'visionary innovation and performance' and 'customer impact'. Quintiles scored highly in all criteria, and particularly so in 'pioneering best practices' and 'addressing biopharma's unmet needs'".

"For example, Quintiles launched a dedicated medical devices unit in Asia Pacific in 2015 that leverages the expertise of Novella Clinical, a Quintiles company. It also introduced a custom-tailored set of solutions for Asia Pacific emerging biopharma. Both of these are fast-growing market sectors and ones in which government and industry are trying to build capabilities. Quintiles is well-positioned to support this growth."

Mr Anand Tharmaratnam, president and head of Asia Pacific, Quintiles said, "This honor belongs to our 10,000 plus employees across Asia Pacific who work every day to improve our customers' probability of success. I believe Asia is entering a new era, one marked by global leadership in biopharma R&D and by diffusion of Asian innovation to global markets".

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Is value- based patient healthcare system more effective in Asian countries?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls